Published in Health and Medicine Week, September 1st, 2003
According to a study from Japan, "To evaluate colorectal cancer screening with fecal occult blood testing (FOBT) in terms of prevention of advanced cancers, we conducted a case-control study in the areas where an annual screening program with immunochemical FOBT has been offered to all inhabitants aged 40 years or over.
"Cases were 357 consecutive patients in the study areas clinically diagnosed as having advanced colorectal cancer or a tumor invading the muscularis propriae or deeper, that is, T-2-T-4 in TNM classification," wrote M. Nakajima and colleagues, Hirosaki...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.